نتایج جستجو برای: proguanil

تعداد نتایج: 315  

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012
Gregory A Deye R Scott Miller Lori Miller Carola J Salas Donna Tosh Louis Macareo Bryan L Smith Susan Fracisco Emily G Clemens Jittawadee Murphy Jason C Sousa J Stephen Dumler Alan J Magill

BACKGROUND We conducted a randomized, placebo-controlled, double-blind trial to establish the efficacy of atovaquone-proguanil to prevent malaria with the goal of simulating weekly dosing in a human Plasmodium falciparum challenge model. METHODS Thirty volunteers randomly received 1 of the following dose regimens: (1) 250 milligrams of atovaquone and 100 milligrams of proguanil (250/100 milli...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003
Steffen Borrmann Jean-François Faucher Thierry Bagaphou Michel A Missinou Ronald K Binder Sophia Pabisch Philipp Rezbach Pierre-Blaise Matsiegui Bertrand Lell Gerri Miller Peter G Kremsner

Malaria-related morbidity and mortality are greatest among young children in areas with high malaria transmission intensity. An open-label, randomized study was done to evaluate the efficacy and safety of the combination of atovaquone and proguanil formulated as pediatric-strength tablets (20 and 8 mg/kg of body weight, respectively, administered once daily for 3 days), compared with amodiaquin...

Journal: :The Journal of pharmacology and experimental therapeutics 2014
Martin Lochner Andrew J Thompson

Proguanil is an antimalarial prodrug that is metabolized to 4-chlorophenyl-1-biguanide (CPB) and the active metabolite cycloguanil (CG). These compounds are structurally related to meta-chlorophenyl biguanide (mCPBG), a 5-hydroxytryptamine 3 (5-HT3) receptor agonist. Here we examine the effects of proguanil and its metabolites on the electrophysiology and ligand-binding properties of human 5-HT...

Journal: :The Cochrane database of systematic reviews 2005
A Osei-Akoto L Orton S P O Owusu-Ofori

BACKGROUND Many conventional treatments for uncomplicated malaria are failing because malaria parasites develop resistance to them. One way to combat this resistance is to treat people with a combination of drugs, such as atovaquone-proguanil. OBJECTIVES To compare atovaquone-proguanil with other antimalarial drugs (alone or in combination) for treating children and adults with uncomplicated ...

2017
Benedetta Terziroli Beretta‐Piccoli Giorgina Mieli‐Vergani Raffaela Bertoli Luca Mazzucchelli Charity Nofziger Markus Paulmichl Diego Vergani

We report a novel association between the commonly used antimalarial medication atovaquone/proguanil and drug-induced autoimmune-like hepatitis. The patient developed severe liver disease fulfilling biochemical, immunologic, and histologic criteria for the diagnosis of autoimmune hepatitis after the inadvertent rechallenge with the offending drug, which had caused self-limited hepatitic symptom...

Journal: :BMJ 2003
Michael J Goldacre Julie Evans Trevor W Lambert

had a few convulsions but no impaired consciousness or other signs of severe malaria. On day 2 the parasitaemia was 4%. Treatment was changed to mefloquine, which was successful. His 4 year old brother, case 2, was febrile with 0.5% infected erythro-cytes. His symptoms resolved with atovaquone and proguanil hydrochloride, and the parasites were cleared after three days. On day 28 he was again f...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید